164 related articles for article (PubMed ID: 36890832)
1. Correlation of serum IGF-1, AGEs and their receptors with the risk of colorectal cancer in patients with type 2 diabetes mellitus.
Chen Z; Hong Q
Front Oncol; 2023; 13():1125745. PubMed ID: 36890832
[TBL] [Abstract][Full Text] [Related]
2. [The expression and significance of IGF1R-Ras/RAGE-HMGB1 pathway in colorectal cancer patients with type 2 diabetes mellitus].
Niu S; Zhao ZG; Lyu XM; Zhao M; Wang XZ; Liu WN; Zhao W; Zhang XH; Wang Y
Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):391-395. PubMed ID: 32482028
[No Abstract] [Full Text] [Related]
3. Circulating soluble receptor for advanced glycation end products and other factors in type 2 diabetes patients with colorectal cancer.
Zhou X; Lin N; Zhang M; Wang X; An Y; Su Q; Du P; Li B; Chen H
BMC Endocr Disord; 2020 Nov; 20(1):170. PubMed ID: 33187505
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of a disintegrin and metalloproteinase 10 in peripheral blood mononuclear cells in type 2 diabetes mellitus patients with the acute coronary syndrome: a pilot study.
Ragavi R; Adole PS; Vinod KV; Pillai AA
Endocrine; 2022 Sep; 77(3):461-468. PubMed ID: 35877008
[TBL] [Abstract][Full Text] [Related]
5. mRNA expression of IGF-1 and IGF-1R in patients with colorectal adenocarcinoma and type 2 diabetes.
Liu R; Hu LL; Sun A; Cao YJ; Tang T; Zhang XP; Zhang QH
Arch Med Res; 2014 May; 45(4):318-24. PubMed ID: 24751329
[TBL] [Abstract][Full Text] [Related]
6. The clinicopathological and prognostic significances of IGF-1R and Livin expression in patients with colorectal cancer.
Zhang Z; Zhang Y; Lao S; Qiu J; Pan Z; Feng X
BMC Cancer; 2022 Aug; 22(1):855. PubMed ID: 35931997
[TBL] [Abstract][Full Text] [Related]
7. RAGE and AGEs in Mild Cognitive Impairment of Diabetic Patients: A Cross-Sectional Study.
Wang P; Huang R; Lu S; Xia W; Cai R; Sun H; Wang S
PLoS One; 2016; 11(1):e0145521. PubMed ID: 26745632
[TBL] [Abstract][Full Text] [Related]
8. Systemic analysis of different colorectal cancer cell lines and TCGA datasets identified IGF-1R/EGFR-PPAR-CASPASE axis as important indicator for radiotherapy sensitivity.
Chen L; Zhu Z; Gao W; Jiang Q; Yu J; Fu C
Gene; 2017 Sep; 627():484-490. PubMed ID: 28687332
[TBL] [Abstract][Full Text] [Related]
9. Higher Expression of Proteins in IGF/IR Axes in Colorectal Cancer is Associated with Type 2 Diabetes Mellitus.
Ding J; Li C; Tang J; Yi C; Liu JY; Qiu M
Pathol Oncol Res; 2016 Oct; 22(4):773-9. PubMed ID: 27138191
[TBL] [Abstract][Full Text] [Related]
10. Expressions of IGF-1R and Ki-67 in breast cancer patients with diabetes mellitus and an analysis of biological characteristics.
Yan X; Gao Z; Zhou Y; Gao F; Li Q
Pak J Med Sci; 2022; 38(1):281-286. PubMed ID: 35035440
[TBL] [Abstract][Full Text] [Related]
11. Low levels of serum soluble receptors for advanced glycation end products, biomarkers for disease state: myth or reality.
Prasad K
Int J Angiol; 2014 Mar; 23(1):11-6. PubMed ID: 24627612
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum levels of advanced glycation end products and their monocyte receptors in patients with type 2 diabetes.
Su XD; Li SS; Tian YQ; Zhang ZY; Zhang GZ; Wang LX
Arch Med Res; 2011 Oct; 42(7):596-601. PubMed ID: 22100610
[TBL] [Abstract][Full Text] [Related]
13. Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes.
Humpert PM; Djuric Z; Kopf S; Rudofsky G; Morcos M; Nawroth PP; Bierhaus A
Cardiovasc Diabetol; 2007 Mar; 6():9. PubMed ID: 17343760
[TBL] [Abstract][Full Text] [Related]
14. Circulating Levels of the Soluble Receptor for AGE (sRAGE) during Escalating Oral Glucose Dosages and Corresponding Isoglycaemic i.v. Glucose Infusions in Individuals with and without Type 2 Diabetes.
Fotheringham AK; Bagger JI; Borg DJ; McCarthy DA; Holst JJ; Vilsbøll T; Knop FK; Forbes JM
Nutrients; 2020 Sep; 12(10):. PubMed ID: 32987824
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes.
Tam XH; Shiu SW; Leng L; Bucala R; Betteridge DJ; Tan KC
Clin Sci (Lond); 2011 Jan; 120(2):81-9. PubMed ID: 20726839
[TBL] [Abstract][Full Text] [Related]
16. Association of insulin-like growth factor-I receptor polymorphism with colorectal cancer development.
Stanilov NS; Karakolev IA; Deliysky TS; Jovchev JP; Stanilova SA
Mol Biol Rep; 2014 Dec; 41(12):8099-106. PubMed ID: 25189651
[TBL] [Abstract][Full Text] [Related]
17. Could AGE/RAGE-Related Oxidative Homeostasis Dysregulation Enhance Susceptibility to Pathogenesis of Cardio-Metabolic Complications in Childhood Obesity?
Corica D; Aversa T; Ruggeri RM; Cristani M; Alibrandi A; Pepe G; De Luca F; Wasniewska M
Front Endocrinol (Lausanne); 2019; 10():426. PubMed ID: 31316471
[No Abstract] [Full Text] [Related]
18. Elevated endogenous secretory receptor for advanced glycation end products (esRAGE) levels are associated with circulating soluble RAGE levels in diabetic children.
Saito R; Araki S; Yamamoto Y; Kusuhara K
J Pediatr Endocrinol Metab; 2017 Jan; 30(1):63-69. PubMed ID: 27941172
[TBL] [Abstract][Full Text] [Related]
19. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.
Tan KC; Shiu SW; Chow WS; Leng L; Bucala R; Betteridge DJ
Diabetologia; 2006 Nov; 49(11):2756-62. PubMed ID: 16969649
[TBL] [Abstract][Full Text] [Related]
20. Serum GLP-1 and IGF-1 levels are candidate diagnostic biomarkers for type 2 diabetes mellitus complicated by coronary heart disease.
Wang J; Chen X; Zhao Y
Am J Transl Res; 2023; 15(3):2033-2039. PubMed ID: 37056864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
